Wuhan Ebitda from 2010 to 2024

600345 Stock   29.69  1.20  4.21%   
Wuhan Yangtze's EBITDA is decreasing over the years with slightly volatile fluctuation. EBITDA is expected to dwindle to about 136.6 M. From 2010 to 2024 Wuhan Yangtze EBITDA quarterly data regression line had arithmetic mean of  217,158,914 and r-squared of  0.60. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
175.7 M
Current Value
136.6 M
Quarterly Volatility
72.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Wuhan Yangtze financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wuhan Yangtze's main balance sheet or income statement drivers, such as Interest Expense of 1.5 M, Selling General Administrative of 69.2 M or Total Revenue of 434.6 M, as well as many indicators such as . Wuhan financial statements analysis is a perfect complement when working with Wuhan Yangtze Valuation or Volatility modules.
  
This module can also supplement various Wuhan Yangtze Technical models . Check out the analysis of Wuhan Yangtze Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Wuhan Stock

Wuhan Yangtze financial ratios help investors to determine whether Wuhan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wuhan with respect to the benefits of owning Wuhan Yangtze security.